Detection of residual prostate cancer after radical prostatectomy with the Abbott IMx PSA assay

Urology

Volumn 47, Issue 6, 1996, Pages 878-881

  Schild, Steven E ^a   Wong, William W ^a   Novicki, Donald E ^a   Ferrigni, Robert G ^a   Swanson, Scott K ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; DIAGNOSTIC VALUE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY;

EID: 0030005603     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(96)00050-7     Document Type: Article

References (17)

1. Wang, MC, Valenzuela LA, Murphy GP, and Chu TM: Purification of a human prostate specific antigen. Invest Urol 17: 159-163, 1979.
2. Tepper SL, Jagirdar J, Heath D, and Geller SA: Homology between the female paraurethral (Skene's) glands and the prostate: immunohistochemical demonstration. Arch Pathol Lab Med 108: 423-425, 1984.
3. Oesterling JE, Chan DW, Epstein JI, Kimball AW Jr, Bruzek DJ, Rock RC, Brendler CB, and Walsh PC: Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J Urol 139: 766-772, 1988.
4. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, and Redwine E: Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317: 909-916, 1987.
5. Huber PR, Schnell Y, Hering F, and Rutishauser G: Prostate specific antigen. Experimental and clinical observations. Scand J Urol Nephrol Suppl 104: 33-39, 1987.
6. Morote J, Ruibal A, and Palou J: Evaluation of specific antigen and prostatic acid phosphatase specificity. Study of false values. Int J Biol Markers 1: 141-146, 1986.
7. Ercole CJ, Lange PH, Mathisen M, Chiou RK, Reddy PK, and Vessella RL: Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer. J Urol 138: 1181-1184, 1987.
8. Rainwater LM, Morgan WR, Klee GG, and Zincke H: Prostate-specific antigen testing in untreated and treated prostatic adenocarcinoma. Mayo Clin Proc 65: 1118-1126, 1990.
9. Lange PH, Ercole CJ, Lightner DJ, Fraley EE, and Vessella R: The value of serum prostate specific antigen determinations before and after radical prostatectomy. J Urol 141: 873-879, 1989.
10. Takayama TK, Vessella RL, Brawer MK, Noteboom J, and Lange PH. The enhanced detection of persistent disease after prostatectomy with a new prostate specific antigen immunoassay. J Urol 150: 374-378, 1993.
11. Carter HB, Partin AW, Oesterling JE, Weber JP, Epstein JI, Chan DW, Rock RC, and Walsh PC. The use of PSA in the management of patients with prostate cancer: The Johns Hopkins experience, in Catalona WJ, Coffey DS, and Karr JP (Eds): Clinical Aspects of Prostate Cancer. New York, Elsevier Science Publishing Co., 1989, pp. 247-254.
12. Morgan WR, Zincke H, Rainwater LM, Myers RP, and Klee GG: Prostate specific antigen values after radical retropubic prostatectomy for adenocarcinoma of the prostate: impact of adjuvant treatment (hormonal and radiation). J Urol 145: 319-323, 1991.
13. Hudson MA, Bahnson RR, and Catalona WJ. Clinical use of prostate specific antigen in patients with prostate cancer. J Urol 142: 1011-1017, 1989.
14. Stamey TA, Kabalin JN, McNeal JE, Johnstone IM, Freiha F, Redwine EA, and Yang N. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients. J Urol 141: 1076-1083, 1989.
15. Prestigiacomo AF, and Stamey TA: A comparison of 4 ultrasensitive prostate specific antigen assays for early detection of residual cancer after radical prostatectomy. J Urol 152: 1515-1519, 1994.
16. Kaplan EL, and Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958.
17. Schild SE, Wong WW, Grado GL, Buskirk SJ, Robinow JS, and Ferrigni RL: The use of radiotherapy for isolated increases in serum prostate-specific antigen levels after radical prostatectomy. Mayo Clin Proc 69: 613-619, 1994.